Showing results (51-60 of 68) with videos related to

Sort By:
Pageof 7
European Urology|June 4, 2023
A Randomized, Open-label, Cross-over Phase 2 Trial of Darolutamide and Enzalutamide in Men with Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer: Patient Preference and Cognitive Function in ODENZAEmeline Colomba, Sarah Flora Jonas, Jean-Christophe Eymard, et al.
Breast (Edinburgh, Scotland)|May 8, 2020
Impact of age at diagnosis of metastatic breast cancer on overall survival in the real-life ESME metastatic breast cancer cohortSophie Frank, Matthieu Carton, Coraline Dubot, et al.
Cancers|February 25, 2023
Long-Term Results with Everolimus in Advanced Hormone Receptor Positive Breast Cancer in a Multicenter National Real-World Observational StudyHélène François-Martin, Audrey Lardy-Cléaud, Barbara Pistilli, et al.
Therapeutic Advances in Medical Oncology|January 27, 2022
Real-world evidence of the management and prognosis of young women (⩽40 years) with de novo metastatic breast cancerAmélie Mallet, Amélie Lusque, Christelle Levy, et al.
Breast (Edinburgh, Scotland)|March 17, 2022
Efficacy of trastuzumab emtansine (T-DM1) and lapatinib after dual HER2 inhibition with trastuzumab and pertuzumab in patient with metastatic breast cancer: Retrospective data from a French multicenter real-life cohortFabien Moinard-Butot, Caroline Saint-Martin, Carole Pflumio, et al.
Annals of Surgery|February 3, 2021
Early Locoregional Breast Surgery and Survival in de novo Metastatic Breast Cancer in the Multicenter National ESME CohortJudicaël Hotton, Amélie Lusque, Léa Leufflen, et al.
The Lancet. Oncology|April 2, 2016
Bevacizumab plus neoadjuvant chemotherapy in patients with HER2-negative inflammatory breast cancer (BEVERLY-1): a multicentre, single-arm, phase 2 studyFrançois Bertucci, Mahmoud Fekih, Aurélie Autret, et al.
Anticancer Research|July 5, 2020
Real-world Evaluation of Oral Vinorelbine in the Treatment of Metastatic Breast Cancer: An ESME-MBC StudyPierre Heudel, Suzette Delaloge, Damien Parent, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 14, 2020
Radiation therapy to the primary tumor for de novo metastatic breast cancer and overall survival in a retrospective multicenter cohort analysisElvire Pons-Tostivint, Youlia Kirova, Amélie Lusque, et al.
Annals of Surgical Oncology|December 13, 2018
Survival Impact of Locoregional Treatment of the Primary Tumor in De Novo Metastatic Breast Cancers in a Large Multicentric Cohort Study: A Propensity Score-Matched AnalysisElvire Pons-Tostivint, Youlia Kirova, Amélie Lusque, et al.
Pageof 7